Biotech Business Week
Susan Hasty, Publisher
Table of Contents . . . March 31st, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Biotech Business Week | Other Publications
Hypogonadism - Testosterone product to be commercialized
Ischemic Stroke - Argatroban meets primary endpoints in phase II study
Biochips - SealChip is focus of three sessions at scientific meeting
Corporate Update - Product, pipeline update provided by cancer drug maker
Microfluidics - Two new LabChip devices introduced for drug discovery screening
Antiviral Therapy - Interim data to be presented on phase IIb study in HIV/AIDS
Cardiology Diagnostics - FDA clearance granted for new chest pain screen
Chemotherapy - Antinausea drug will likely get approval in U.S.
Chronic Myeloid Leukemia - Medical journal editorial dubs Gleevec "gold standard"
Corporate Learning - Case study challenge expands to foster skills development
Drug Development - Agreement provides ability to use Captisol for early development
Drug Development - FDA issues follow-up statement on unapproved long-acting Guaifenesin
Finance - Biotech company loses $997,000 in 2002
Finance - Biotech secures $3M line of credit for facility growth
Finance - Pharmaceutical company reports quarterly net loss of $1.18 per common share
Hyperglycemia - Generic formulation of diabetes drug produced
Personal Care Trends - UV absorber suppliers look to Asia for long-term market growth
Protein Analysis - Fully automated chip-based nanoelectrospray launched
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
